Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Domenica Rubino"'
Autor:
Jena S. Tronieri, Anthony N. Fabricatore, Thomas A. Wadden, Pernille Auerbach, Lars Endahl, Danny Sugimoto, Domenica Rubino
Publikováno v:
Obesity Facts, Pp 1-12 (2020)
Introduction: Individuals who enroll in intensive behavioral therapy (IBT) programs are asked to make several lifestyle changes simultaneously. However, few studies have examined the relative effects of adherence to different treatment components on
Externí odkaz:
https://doaj.org/article/aaa1ff0326af4e3b81c7284095a98686
Autor:
Patrick O'Neil, Domenica Rubino
Publikováno v:
Postgraduate Medicine. 134:28-36
Autor:
David C.W. Lau, Domenica Rubino, Kasper K Berthelsen, Michael T. Lund, Martin Kankam, Altynai Satylganova, Lone B Enebo
Publikováno v:
The Lancet. 397:1736-1748
Summary Background Cagrilintide, a long-acting amylin analogue, and semaglutide 2·4 mg, a glucagon-like peptide-1 analogue, are both being investigated as options for weight management. We aimed to determine the safety, tolerability, pharmacokinetic
Autor:
JULIO ROSENSTOCK, W. TIMOTHY GARVEY, BRYAN GOLDMAN, USMAN KHALID, RASMUS SØRRIG, DOMENICA RUBINO
Publikováno v:
Diabetes. 71
The STEP 8 trial randomized 338 adults with overweight/obesity to weekly semaglutide 2.4 mg or placebo (PBO) , or daily liraglutide 3.0 mg or PBO, plus lifestyle intervention for 68 wks (3:1:3:1) ; PBO data not shown. Body weight (BW) change was grea
Autor:
Michael T. Lund, Thomas A. Wadden, Jena Shaw Tronieri, Pernille Auerbach, Domenica Rubino, Danny Sugimoto, Camilla B. Jensen
Publikováno v:
Obesity (Silver Spring, Md.)
Objective Previous studies have shown additive weight loss when intensive behavioral therapy (IBT) was combined with weight-loss medication. The present multisite study provides the first evaluation, in primary care, of the effect of the Centers for
Autor:
Domenica Rubino, Srividya Kidambi, Katherine H. Saunders, Marsha B. Novick, Robert F. Kushner, John A. Batsis, Florencia Halperin, Angela Golden, W. Scott Butsch, Scott Kahan, Ava Port, Taraneh Soleymani, Sriram Machineni, Nicola Davis, Linda Shapiro Manning
Publikováno v:
Obesity. 28:9-17
Eliciting a weight history can provide clinically important information to aid in treatment decision-making. This view is consistent with the life course perspective of obesity and the aim of patient-centered care, one of six domains of health care q
Autor:
Ildiko Lingvay, Sean Wharton, Ofri Mosenzon, Melanie J. Davies, Domenica Rubino, Dror Dicker, Sue D. Pedersen
Publikováno v:
Postgraduate medicine. 134(1)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established in clinical practice for the treatment of type 2 diabetes, and are approved and recommended for weight management in overweight or obesity. Gastrointestinal side effects are we
Autor:
Dan Hesse, Miguel A. Rubio, Niclas Abrahamsson, Dror Dicker, Melanie J. Davies, Ildiko Lingvay, Domenica Rubino, Gottfried Rudolfsky, Camilla B. Jensen, Sayeh Tadayon, Tanja Wiedenmann, Julio Rosenstock, Ofri Mosenzon, Thomas A. Wadden, Frank L. Greenway
Publikováno v:
Adipositas-Kongress 2021 – 37. Jahrestagung der Deutschen Adipositas-Gesellschaft e.V..
Autor:
Thomas A. Wadden, René Gollan, Domenica Rubino, Patrick M. O'Neil, Timothy Garvey, Juan P. Frias, Timothy S. Bailey, Dorothe Skovgaard, Signe O R Wallenstein, Anna Koroleva, Liana K. Billings
Publikováno v:
Adipositas-Kongress 2021 – 37. Jahrestagung der Deutschen Adipositas-Gesellschaft e.V..
Autor:
Ildiko Lingvay, Melanie J. Davies, Dror Dicker, Ofri Mosenzon, Mette Thomsen, Thomas A. Wadden, Bryan Goldman, Sue D. Pedersen, Domenica Rubino, Salvatore Calanna, Sean Wharton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abb435fb4d15a1accf85ea4743d469a3
https://doi.org/10.1111/dom.14551/v2/response1
https://doi.org/10.1111/dom.14551/v2/response1